| 1 |
Partly verified |
Full text not readStored summary read |
N01 · Evidence conditionWhich original one-year recurrence claim is selected?Required |
The selected claim is reduced same-ankle recurrence over one year, original subclaim grade B, with the note 22% versus 33%/NNT 9. Absent subclaim score/status/axes are preserved separately from parent B with 76 points and axes. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Selected subclaim wording/grade versus parent context |
Materials needed: Exact same-ankle recurrence definition, population/comparator, duration/denominators and user boundary review. Parent scores do not fill the subclaim score. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 2 |
Partly verified |
Full text not readStored summary read |
N02 · Evidence conditionWhich previous-sprain population was studied?Required |
2BFit randomized 522 athletes aged 12–70. The original intervention was home training after usual care following ankle sprain. Injury severity, recovery/start criteria, sports/comorbidities are not established in detail by the summary. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Athletes aged 12–70 after ankle sprain |
Materials needed: Eligibility/exclusions, previous sprain/severity, usual care, training start, exposure and direct other-population data. Do not extend to all ankle disorders/app users. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 3 |
Partly verified |
Full text not readStored summary read |
N03 · Evidence conditionWhat was the specific delivery approach?Required |
The original was eight weeks of home neuromuscular training supplying a balance board, exercise sheets, DVD and web materials. Do not simplify into the board’s isolated-component effect, all ankle exercise or app effects. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Eight-week program with balance board, exercise sheets, DVD and web materials |
Materials needed: Components, support/contact, training content, adherence, actual products and direct comparisons of delivery approaches. No device/app recommendations or exercise instructions. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 4 |
Partly verified |
Full text not readStored summary read |
N04 · Evidence conditionWhat were usual-care comparison and concurrent treatment?Required |
Original design was a multicentre randomized usual-care-controlled trial; effects concern adding an eight-week program after usual care. Actual concurrent bracing, physiotherapy, medication, return-to-sport/exposure in both arms remain unverified. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Additional training after usual care |
Materials needed: Original usual care, additional training/other exposure, contact, contamination and recovery/return criteria in both arms. Do not repurpose effects to no treatment/other comparators. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 5 |
Partly verified |
Full text not readStored summary read |
N05 · Evidence conditionAre training duration/study exposure separated from use instructions?Required |
Original study facts record three sessions weekly, up to 30 minutes each, for eight weeks. Preserve study-exposure identity only; do not calculate total sessions/time or create exercise/rehabilitation/prevention instructions. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Original eight weeks, three times weekly, up to 30 minutes |
Materials needed: Original actual training, adherence/stopping, support/contact and phase-specific exposure. No certification of identical effects for other durations/intensities. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 6 |
Partly verified |
Full text not readStored summary read |
N06 · Evidence conditionAre eight-week training and one-year outcomes separated?Required |
Intervention lasted eight weeks and same-ankle recurrence follow-up lasted 12 months. Maintenance training after completion, follow-up exposure/stopping and visit-specific observation remain unverified in detail. Training and event-observation periods do not become the same denominator. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Intervention duration versus 12-month recurrence follow-up |
Materials needed: Original actual training/maintenance, follow-up schedules, observation duration/loss and sports exposure. Do not calculate new day counts/exercise amounts from one year. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 7 |
Partly verified |
Full text not readStored summary read |
N07 · Evidence conditionWhat are randomization and recurrence numerators?Required |
The original records 522 randomized (256/266) and 56/256 (22%) versus 89/266 (33%). Separately retain relationships among people, ankles, recurrence events, repeated reports and time; do not calculate additional event/participant totals. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
522 participants, 256/266, original recurrence 56/89 |
Materials needed: Endpoint-numerator definitions, arm analysis/follow-up/observed denominators, repeated-recurrence handling and original flow tables. Do not copy numerators/denominators to all other endpoints/trials. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 8 |
Partly verified |
Full text not readStored summary read |
N08 · Evidence conditionHow was same-ankle recurrence defined?Required |
The original endpoint was same-ankle recurrence reported monthly and independently adjudicated under masking. Diagnostic/injury/recurrence criteria, first/all-repeated-event handling and clinical-confirmation details remain unverified. Do not extend to the opposite ankle/all injuries. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Original event label, first/repeated events and confirmation |
Materials needed: Event definitions, original questionnaires, adjudication rules, repeated/contralateral events, severity and confirmation data. Materials clarifying aggregation of original numerators 56/89. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 9 |
Partly verified |
Full text not readStored summary read |
N09 · Evidence conditionAre self-reporting and masked adjudication separated?Required |
The original records monthly self-reports followed by independent adjudication by a masked physiotherapist and researcher. Initial reporting was self-reported and participant masking impossible. Do not add a declaration that all reports were confirmed through testing/clinical visits. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Initial monthly reporting versus independent physiotherapist/researcher adjudication |
Materials needed: Original reporting/missingness, disagreement/adjudication, assessor masking, objective confirmation and participant expectations. No formal RoB assessment in this production. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 10 |
Partly verified |
Full text not readStored summary read |
N10 · Evidence conditionAre recurrent people, repeated events and observations separated?Required |
Preserve original 56/256, 89/266 and monthly reporting. Exact aggregation of at-least-one recurrence, first/all-repeated events and same-person bilateral-ankle/report relationships remains unverified. Monthly/repeated events are not new independent participants. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Original numerators and people/ankle/event units |
Materials needed: Original event aggregation, person/ankle identifiers, repeat handling, analysis units and observation periods. No additional participant/event counts or new incidence-rate calculations. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 11 |
Partly verified |
Full text not readStored summary read |
N11 · Evidence conditionWhich comparison do adjusted RR/CI/NNT describe?Required |
Original adjusted RR 0.63 (95% CI 0.45–0.88) and NNT 9 concern 2BFit same-ankle recurrence over one year. Do not copy to app/bracing or time-loss/cost endpoints. Original adjusted-model/estimand details remain unverified. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
2BFit one-year recurrence effects |
Materials needed: Original models/adjustment variables, effects/CI, NNT definition/denominators and estimands. No new RR/RRR/NNT/CI recalculation or invented examples. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 12 |
Partly verified |
Full text not readStored summary read |
N12 · Evidence conditionAre original absolute difference and arm percentages distinguished?Required |
The original crux/rationale records 22% versus 33% and absolute recurrence difference −11 percentage points. Do not transfer to within-arm improvement, relative effects, other ankles/apps or calculate exact unrounded values/new absolute differences. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
22% versus 33% and original −11 percentage points |
Materials needed: Original arm denominators/rounding, effect definitions, adjusted/unadjusted results and duration/analysis data. Do not newly convert RR and absolute differences into one another. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 13 |
Partly verified |
Full text not readStored summary read |
N13 · Evidence conditionAre exposure-time incidence density and one-year risk identical?Required |
Original study facts record incidence density 1.86 versus 2.90 per 1,000 ankle-exposure hours. These differ in units from 22% versus 33% with person denominators. Do not calculate actual total exposure hours, new event counts/incidence-density ratios. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
1.86 versus 2.90 per 1,000 hours |
Materials needed: Actual arm sports exposure, recording/missingness, incidence-density numerators/denominators and models/CI. Distinguish time, people and ankle units. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 14 |
Partly verified |
Full text not readStored summary read |
N14 · Evidence conditionAre time-loss and cost/productivity outcomes retained separately?Required |
The original rationale records time-loss recurrence RR 0.53 and medical-cost/productivity-loss recurrence RR 0.25 in the same direction. Definitions, numerators/denominators, CI/times/models remain unverified in detail. Do not copy primary RR 0.63/CI or NNT 9. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Other recurrence outcomes, RR 0.53 and 0.25 |
Materials needed: Original endpoint tables, event/cost definitions, denominators, effects/CI and hierarchy/multiplicity. No new calculations/addition beyond original numbers. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 15 |
Partly verified |
Full text not readStored summary read |
N15 · Evidence conditionAre adherence, comparator contamination and attrition retained together?Required |
Preserve original full adherence 58/256 (23%), comparator contamination 5/266 (2%) and follow-up attrition 14%. Adherence definition, partial adherence and arm-specific loss/reasons remain unverified in detail. No adherer effects, new adherence differences/attrition counts/rates. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
58/25623%·5/2662%·14% |
Materials needed: Adherence measurement, actual exposure, contamination/concurrent training, arm withdrawal/missingness and sensitivity analyses. Low adherence does not newly establish delivery effects/causality. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 16 |
Partly verified |
Full text not readStored summary read |
N16 · Evidence conditionDoes ITT certify resolution of completeness/missingness?Required |
The original study description records all analyses following ITT principles alongside 14% attrition. ITT is not converted into universal completion/all-endpoint observation or zero missingness bias. Original B0 is parent-verdict context. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Analysis as randomized and actual missingness handling |
Materials needed: Original arm flow, endpoint analysis/observation, missingness handling/assumptions, follow-up loss and sensitivity. No clinical calculations/formal risk assessment in this production. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 17 |
Partly verified |
Full text not readStored summary read |
N17 · Evidence conditionAre original randomization/prespecified-endpoint descriptions preserved?Required |
The original records independent-researcher computer allocation, impossible participant masking/masked adjudication, ITT, and matching prespecified self-reported recurrence primary endpoint/ISRCTN34177180. Preserve original quotations/history only; no plan/procedure comparison now. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Independent-researcher computer allocation and recurrence primary endpoint/registration |
Materials needed: Allocation concealment/implementation, plans/amendments, registration versions/public dates and original-report comparison. The unestablished first registration publication date does not newly establish prospective registration. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 18 |
Partly verified |
Full text not readStored summary read |
N18 · Evidence conditionAre 2023 app results mixed with 2BFit?Required |
The original counterview records a primary-care app trial with 165 participants, null HR 1.14 (0.59–2.21), adherence 6.1%. Preserve the original scope that delivery differed from 2BFit supplying a board/DVD and was not counted as direct conflict. Citation/design details remain unidentified. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Different-delivery trial, 165 participants, HR 1.14 |
Materials needed: Exact app citations/registration, population/comparator/duration, endpoints/denominators/exposure/adherence, models and direct comparisons. Do not substitute app HR for board RR or effects of all apps. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 19 |
Partly verified |
Full text not readStored summary read |
N19 · Evidence conditionAre different bracing-trial/review results separated?Required |
The original records 12-month bracing superior to eight-week training in the 2014 trial and no 12-month recurrence difference between training/bracing in a 2017 review. Populations, citations, denominators, effects and CI for both contexts remain unverified; no difference does not become equivalence. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
2014 bracing superiority and no difference in 2017 |
Materials needed: Each citation, original trials/review-included studies/overlap, exact comparators/durations and effects/CI/denominators. Do not count different research as new pooled effects/unique trial totals. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 20 |
Unverified |
Full text not readStored summary read |
N20 · Harm-information gaps supplementing the efficacy tableIs the separate exercise-harm reporting gap retained?Supplementary |
The original safety description records that exercise-related adverse events were not collected/reported in a separate table and this trial cannot establish harmlessness. Preserve this reporting limitation; do not extend to zero AE or long-term safety. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Exercise-related AE collection/reporting versus harmlessness |
Materials needed: Harm collection/definitions, arm actual training/exposure, events/discontinuation/relatedness/denominators and long-term data. No exercise/rehabilitation/recurrence-prevention instructions. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 21 |
Partly verified |
Full text not readStored summary read |
N21 · Evidence conditionWhat was actually read/identified?Required |
The complete preserved parent summary was read for production and retained in the original archive. The single citation identifies 2BFit; three app/bracing/review entries are unidentified counterview contexts. All external abstracts/full texts/registration/plans remain unread. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Preserved summary/original citation versus unidentified reference contexts |
Materials needed: Exact report citations/originals, acquisition/reading scope, versions/dates. URLs/historical quotations are not upgraded to current reading; no external-link/access testing. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 22 |
Partly verified |
Full text not readStored summary read |
N22 · Evidence conditionAre registration dates/prespecification treated as current certification?Required |
Original evidence/Korean text describes matching ISRCTN34177180 with the self-reported recurrence primary endpoint. Original study facts say the first registration public date was unestablished, so prospective registration was not asserted. App/bracing/review registrations are unidentified. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
ISRCTN34177180 and unestablished first public date |
Materials needed: Actual registration versions/publication, start/amendment timing and endpoints/plans. No guessed official URLs, new registration reading or prespecification certification. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 23 |
Unverified |
Full text not readStored summary read |
N23 · Evidence conditionWere protocol/SAP and estimand/missingness plans acquired?Required |
Preserve original primary/ITT/allocation/adjudication descriptions and historical cross-checking. Each trial’s protocol/SAP, versions/timing and missingness/multiplicity/analysis plans were not acquired/read now. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Separate prespecified-plan/analysis/amendment materials |
Materials needed: Original protocols/SAP, amendment histories, endpoints/models/people/events/exposure, missingness/sensitivity and public timing. Unread external materials do not establish document absence. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 24 |
Partly verified |
Full text not readStored summary read |
N24 · Evidence conditionAre public funding, board supply and company involvement separated?Required |
2BFit had ZonMw grant 750-20-002, declarations of no financial benefit/competing interests and Avanco AB boards supplied to participants. Preserve the original limitation that manufacturer donation/funding/analysis/writing/publication support was not reported. Supply is not manufacturer donation; employee authors/roles and app/bracing/review funding remain unverified now. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
2BFit support versus unverified other contexts |
Materials needed: Item-specific company funding, product support, employee authors, design/analysis/data control and other support for each study. I2 does not establish absence of every item or independence certification. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 25 |
Partly verified |
Full text not readStored summary read |
N25 · Evidence conditionAre specific positive effects, different-delivery null results and unverified details distinguished?Required |
Positive 2BFit recurrence, null 2023 app HR, 2014 bracing superiority and no difference in the 2017 review concern different contexts. Separate original descriptions from unverified citation/effect/harm details; no new verdict on broad claims. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Question/comparison-specific results and reading status |
Materials needed: Report-specific direct populations/interventions/comparators, endpoints/durations, effects/CI/denominators and actual access. Unread does not mean unreported; null does not mean zero effect/equivalence. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 26 |
Partly verified |
Full text not readStored summary read |
N26 · Evidence conditionAre one original citation and three reference contexts counted as unique trials?Required |
Parent 2975 and its s0/s1 claims share original 2BFit citation/trial context and counterview mentions of the 2023 app, 2014 bracing and 2017 review. The same people, ankles, arms, events, times, citations, related sheets and review-included trials are not newly added as independent trials/participants. Four links comprise one identified paper and three unidentified contexts, including a 2017 review; they are not certification of four unique clinical trials or participant totals. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Document/context items versus trials/participants |
Materials needed: Citations/registration, review-included reports/overlap, cohorts/analysis, endpoints/repetition relationships. Unique trial/participant totals remain unrecorded. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 27 |
Unverified |
Full text not readStored summary read |
N27 · Evidence conditionAre original single confirmation and independent replication distinguished?Supplementary |
Preserve parent replication R1/independence I2 and the original single confirmatory-trial description. App/bracing/review contexts are not counted as new same-condition independent replication/conflicts or unique-trial certification. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Parent R1/I2 and comparison/delivery differences |
Materials needed: Separate prespecified, direct population/delivery/comparator/events, effects/CI/denominators, funding/author relationships and overlap materials for the selected question. No search/independence determination now. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 28 |
Partly verified |
Full text not readStored summary read |
N28 · Evidence conditionAre the subclaim grade and parent score/axes preserved?Required |
Preserve selected subclaim B/note/bilingual claims; absent subclaim score/status/axes remain unrecorded. Parent B with 76 points, unknown safety, B/H/R1/I2/E+/B0, unrecorded precision and true large-hard-endpoint RCT are parent context and do not fill subclaim values. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Selected B, absent subclaim values and parent B76 |
Materials needed: User subclaim/parent-boundary review and actual correction materials. No new score/grade or official RoB 2/GRADE certification. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 29 |
Partly verified |
Full text not readStored summary read |
N29 · Evidence conditionAre both languages, citations and absent fields preserved?Required |
Preserve original parent bilingual quotations/descriptions, evidence, citations and axes and selected-subclaim values in the complete original archive. Classification fields are absent and no new original fields are filled. No English-paper comparison now. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Both original languages and absent separate classification information |
Materials needed: User review of languages/terminology, event/exposure units, absences and selected scope. Distinguish production descriptions from original values. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 30 |
Partly verified |
Full text not readStored summary read |
N30 · Evidence conditionAre source dates/corrections/history separated from production dates?Required |
Preserve original evidence date 2026-08-26, empty corrections/deliberation and verdict-decision cross-checking. Historical quotations/registration matching differ from current production, condition freezing/application and completed content review. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Original 2026-08-26 and new conditions/application |
Materials needed: Update materials separating originals, events, conditions/observations and verdict decisions when new evidence/corrections arise. Historical wording is not completed clinical content review here. Only material requests/research needs are recorded; no search or research was performed in that production. |
| 31 |
Unverified |
Full text not readStored summary read |
N31 · Evidence conditionWhat direct materials would fill the selected gaps?Supplementary |
Specific 2BFit event/exposure, adherence/attrition, harms/reporting details require originals; app/bracing mentions do not substitute as identical effects. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Direct population/delivery/events, effects/CI and denominators |
Materials needed: Question-specific tables/plans, direct comparisons/applicability, effects/CI, people/ankle/event/exposure denominators, missingness/adherence, separate confirmation and long-term harms. Need recorded only; no search/research now. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 32 |
Partly verified |
Full text not readStored summary read |
N32 · Evidence conditionAre applicability records separated from content review and instructions?Supplementary |
These are summary-based applicability records. Existing content/question-boundary review remains incomplete; candidate pending/eligible markers are preserved as history. |
Production observation distinguishing selected/parent, identified reports/reference contexts and comparison/endpoint materials in the preserved summary. Detailed originals remain unverified and existing content review incomplete; this does not establish passed review/clinical certification. |
Applicability records, existing candidate history and content review |
Materials needed: Content review and subsequent actual evidence/correction work. Original content-production scope excludes clinical QA/testing, external-link/access/web/API research, new calculations/grades and device/app recommendations or exercise/rehabilitation/prevention/treatment-replacement instructions. Only material-request/research needs are recorded; no search/research was performed in this production. |